Amit Hazan
Stock Analyst at Goldman Sachs
(2.08)
# 2,997
Out of 5,138 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $96.47 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.99 | -68.71% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.56 | +1,117.95% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $19.35 | -58.66% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $63.19 | -0.30% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $208.35 | +30.55% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $17.44 | -2.52% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $5.26 | +8,169.96% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $30.50 | +44.26% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $84.49 | -13.60% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $20.37 | +160.19% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $24.26 | +134.95% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $17.46 | -45.59% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $123.53 | -15.81% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $21.20 | +183.02% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $99.00 | +16.16% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $362.49 | -58.62% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $90.03 | -48.91% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $541.34 | -55.36% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $88.75 | +99.44% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $219.57 | -33.05% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.87 | +349.00% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $96.47
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.99
Upside: -68.71%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.56
Upside: +1,117.95%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $19.35
Upside: -58.66%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $63.19
Upside: -0.30%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $208.35
Upside: +30.55%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $17.44
Upside: -2.52%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $5.26
Upside: +8,169.96%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $30.50
Upside: +44.26%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $84.49
Upside: -13.60%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $20.37
Upside: +160.19%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $24.26
Upside: +134.95%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $17.46
Upside: -45.59%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $123.53
Upside: -15.81%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $21.20
Upside: +183.02%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $99.00
Upside: +16.16%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $362.49
Upside: -58.62%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $90.03
Upside: -48.91%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $541.34
Upside: -55.36%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $88.75
Upside: +99.44%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $219.57
Upside: -33.05%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.87
Upside: +349.00%